6 episódios

Highlights of the American Academy of Neurology Annual Meetin‪g‬ Projects In Knowledge, Inc

- Ciência

Listen as James D. Bowen, MD, and Augusto A. Miravalle, MD, review some of the most significant MS research presented at the 63rd AAN annual meeting, held April 9-16, 2011, in Honolulu, Hawaii. Dr. Bowen provides updates in the areas of pathology, immunology, genetics, testing, imaging, and cognitive dysfunction. Dr. Miravalle summarizes the latest data on current and emerging therapies.

- 28/04/2011
Emerging Therapies

Emerging Therapies

Data from AAN 2011 on emerging MS therapies, including laquinimod, cladribine, alemtuzumab, and more.
- 10 min
- 28/04/2011
Current Therapies

Current Therapies

Data from AAN 2011 on current MS therapies, including interferon beta, glatiramer acetate, natalizumab, mitoxantrone, and fingolimod.
- 9 min
- 28/04/2011
Cognitive Dysfunction

Cognitive Dysfunction

New research on MS-related cognitive dysfunction from AAN 2011.
- 7 min
- 28/04/2011
Testing, Imaging, Biomarkers, and Predictors

Testing, Imaging, Biomarkers, and Predictors

Reports from AAN 2011 on evolving applications of imaging and testing in MS.
- 11 min
- 28/04/2011
Pathophysiology, Immunology, Genetics, Neuropreservation - Part 2

Pathophysiology, Immunology, Genetics, Neuropreservation - Part 2

Latest research from AAN 2011 on mechanisms of disease progression in MS.
- 5 min
- 28/04/2011
Pathophysiology, Immunology, Genetics, Neuropreservation - Part 1

Pathophysiology, Immunology, Genetics, Neuropreservation - Part 1

Latest research from AAN 2011 on risk factors for and pathogenesis of MS.
- 9 min